2007
DOI: 10.1007/s12013-007-0014-9
|View full text |Cite
|
Sign up to set email alerts
|

Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane

Abstract: AA key feature in Parkinson's disease is the deposition of Lewy bodies. The major protein component of these intracellular deposits is the 140-amino acid protein alpha-synuclein that is widely distributed throughout the brain. alpha-synuclein was identified in presynaptic terminals and in synaptosomal preparations. The protein is remarkable for its structural variability. It is almost unstructured as a monomer in aqueous solution. Self-aggregation leads to a variety of beta-structures, while membrane associati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
99
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 96 publications
(105 citation statements)
references
References 150 publications
6
99
0
Order By: Relevance
“…The DMPS peak shifts upfield by 0.3 ppm, and for DMPC a weaker upfield shift of 0.1 ppm is observed. The observation of an electrostatically driven Lit30-membrane interaction agrees well with studies on other vesicle binding disordered proteins, such as the T cell receptor (Sigalov and Hendricks, 2009), the viral genome-linked protein (Vpg) (Rantalainen et al, 2009), and a-synuclein (Davidson et al, 1998;Beyer, 2007). While Lti30 exhibits a weak affinity for neutral vesicles made of zwitterionic DOPC, presumably due to weak hydrophobic interactions, Lti30 also has a very pronounced interaction with lipids containing the negatively phosphatidic acid DOPA (data not shown).…”
Section: Solid-state 31 P Mas Nmr: Interaction Of Lti30 With Vesiclessupporting
confidence: 84%
“…The DMPS peak shifts upfield by 0.3 ppm, and for DMPC a weaker upfield shift of 0.1 ppm is observed. The observation of an electrostatically driven Lit30-membrane interaction agrees well with studies on other vesicle binding disordered proteins, such as the T cell receptor (Sigalov and Hendricks, 2009), the viral genome-linked protein (Vpg) (Rantalainen et al, 2009), and a-synuclein (Davidson et al, 1998;Beyer, 2007). While Lti30 exhibits a weak affinity for neutral vesicles made of zwitterionic DOPC, presumably due to weak hydrophobic interactions, Lti30 also has a very pronounced interaction with lipids containing the negatively phosphatidic acid DOPA (data not shown).…”
Section: Solid-state 31 P Mas Nmr: Interaction Of Lti30 With Vesiclessupporting
confidence: 84%
“…We show that αS is likely to aggregate via such an intermediate in the presence of TFE, suggesting that membrane-induced αS aggregation may also involve the formation of a helical intermediate. Furthermore, TFE-induced fibrils are β-sheet rich and resemble previously reported aggregates formed by C terminally truncated αS (11), as well as structures induced by detergent and lipid interactions (12,13), which may be linked to PD initiation and progression (14)(15)(16)(17).…”
supporting
confidence: 80%
“…Also, while this paper was in review, a study was published which described detergent-induced formation of species that may be similar to our TFE fibrils (13). Although more research must be done to evaluate whether species produced by truncation mutations and/or lipid and detergent interactions are indeed related to TFE fibrils, the potential similarities with previously observed structures are particularly important in light of the hypothesis that intermediate or alternative oligomeric or fibrillar species are responsible for PD toxicity (23), recent findings that C-terminal truncation of αS can lead to neuron loss and increased susceptibility to stress in transgenic mouse models (14,15), and multiple lines of evidence that potentially link lipid interactions and metabolism with PD etiology (16).…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation
“…The membrane interaction of ␣-synuclein has become of significant interest for the pathological as well as the physiological functions of this protein (4,5). Although its physiological roles are not fully understood, it is thought that ␣-synuclein binds to synaptic vesicles, plays a role in neuronal plasticity, modulates the release of neurotransmitters, plays a role in vesicular trafficking and affects brain lipid metabolism (6 -14).…”
Section: Several Familial Forms Of Parkinson Disease (Pd)mentioning
confidence: 99%